Educational information, not medical advice — ask your doctor or midwife.
Track Bibhitaki with reminders and record whether it helped, in the app.
Bibhitaki (Terminalia bellirica) is one of Ayurveda's most revered fruits, used for over 3,000 years across Indian and Southeast Asian healing traditions. Its name in Sanskrit roughly translates to 'one who keeps away disease,' reflecting its broad therapeutic reputation. It is most widely known as a key component of Triphala alongside Amalaki and Haritaki, but is also used as a standalone remedy for respiratory, digestive, and metabolic concerns.
Bibhitaki is rich in hydrolyzable tannins — particularly gallic acid and ellagic acid — that act as powerful antioxidants and help reduce inflammation throughout the body. These compounds also appear to support healthy cholesterol levels, balance blood sugar, and protect the liver. Its astringent properties help tone mucous membranes in the gut and respiratory tract, making it useful for both loose bowel complaints and excess mucus.
Traditional Ayurvedic use favors the dried powder (churna) mixed with warm water or honey. Standardized capsules and tablets offer more convenient dosing for modern use. Extracts allow for consistent delivery of active tannins. Decoctions brewed from the dried fruit are common in classical preparations.
Bibhitaki has been documented in Ayurvedic classical texts including the Charaka Samhita and Sushruta Samhita dating back over 2,000 years. It was used to treat respiratory conditions, eye disorders, digestive upset, and hair loss, and was considered a rasayana — a rejuvenating tonic that supports longevity and vitality. Its use spread through traditional Southeast Asian and Tibetan medicine systems as well.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.